Obicetrapib Shows Promise for Heart Disease and Alzheimer's Prevention
Peter Attia explores a new CETP inhibitor that may reduce cardiovascular risk and protect against Alzheimer's disease in APOE4 carriers.
20 articles
Peter Attia explores a new CETP inhibitor that may reduce cardiovascular risk and protect against Alzheimer's disease in APOE4 carriers.
A comprehensive guide to sleep pharmacology โ from benzos and Z-drugs to DORAs, trazodone, and the top sleep supplements โ with clinical nuance.
Scientists discover two polyunsaturated fatty acids that may help eliminate aging cells, offering potential longevity benefits.
World-renowned lipidologist Tom Dayspring explains why brain cholesterol operates independently from the body โ and what that means for Alzheimer's.
New research reveals how leaky brain blood vessels may be the root cause of cognitive decline, offering fresh prevention strategies.
Dr. Abud Bakri covers BPC-157, epithalon, GHK-Cu, GLP-1s, and growth hormone peptides โ separating real evidence from hype.
Jim LaValle shares decades of experience with innovative peptides, metabolic testing, and personalized health optimization strategies.
Dr. Fajgenbaum reveals how existing medications can treat diseases they weren't designed for, potentially saving lives.
Neuroscientist Dr. Read Montague reveals how brain chemicals shape learning, motivation, and the hidden costs of instant gratification.
Dr. Dominic D'Agostino shares evidence-based strategies for implementing ketogenic diets to enhance performance and longevity.
Dr. David Berson reveals how your eyes secretly regulate sleep, mood, and circadian rhythms beyond just vision.
Matt Maruca reveals which blue light blockers actually work and debunks common myths about artificial light exposure.
New research reveals vitamin D supplements dramatically reduce dementia risk, even for those genetically predisposed to Alzheimer's disease.
A leading aging researcher audits NMN, urolithin A, spermidine, and more โ revealing what actually works and what falls short.
Attia lays out a rigorous, personalized decision framework for evaluating medications and supplements โ cutting through hype with evidence hierarchy and risk math.
Peter Attia answers listener questions on cardiovascular risk, metabolic health, minimum-dose strength training, dementia prevention, and NAD supplements.
New research reveals surprising cognitive benefits of unprocessed meat for those with Alzheimer's genetic risk factor APOE4.
Leading NAD researcher cuts through supplement hype to reveal what actually raises NAD levels and fights inflammation in humans.
Dr. Rhonda Patrick reveals how magnesium deficiency impairs DNA repair, accelerates aging, and increases disease risk.
Biotech company reports positive preliminary results from clinical trial testing cellular rejuvenation therapy targeting aging cells.